Targeted mouse complement inhibitor CR2-Crry protects against the development of atherosclerosis in mice.
Targeted mouse complement inhibitor CR2-Crry protects against the development of atherosclerosis in mice. Atherosclerosis. 2014 May; 234(1):237-43.